Lin Zhe-Zhong, Wang Jhi-Joung, Chung Chi-Rung, Huang Po-Chang, Su Bo-An, Cheng Kuo-Chen, Chio Chung-Ching, Chien Chih-Chiang
Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan.
Department of Medical Research, Chi-Mei Medical Center, Tainan, Taiwan.
Bone. 2014 Jul;64:235-9. doi: 10.1016/j.bone.2014.04.017. Epub 2014 Apr 26.
Chronic kidney disease increases the risk for hip fractures. Hip fractures are associated with increased mortality, decreased quality of life, and higher economic burden. To determine whether dialysis modality is associated with a higher incidence of hip fractures in patients with end-stage renal disease (ESRD), we used the Taiwan National Health Insurance Research Database to examine the records of 51,473 patients who began dialysis between 1999 and 2005. The patients were followed until death, transplantation, dialysis cessation, or 31 December 2008. The follow-up period was (mean±SD) 4.14±2.48 years. The cumulative incidence rate of hip fracture was calculated using Kaplan-Meier methods. Predictors of hip fracture were determined using Cox models. During the study period, 1903 patients had a hip fracture. The overall incidence rate of hip fracture was 89.21/10,000 patient-years. Patients on hemodialysis (HD) had a 31% higher incidence of hip fracture than those on peritoneal dialysis (PD) (HR 1.31, 95% CI: 1.01-1.70). Patients ≥65 years old had more than 13 times the risk of a hip fracture than did those 18-44 years old (HR: 13.65; 95% CI: 10.12-18.40). Other factors that increased the risk of a hip fracture were a prior hip fracture (HR: 1.44; 95% CI: 1.15-1.80), osteoporosis (HR: 1.24; 95% CI: 1.07-1.45), DM (HR: 1.66; 95% CI: 1.51-1.83), and liver cirrhosis (HR: 1.37, 95% CI: 1.15-1.64). The overall in-hospital mortality rate was 3.2%. The cumulative survival rates after a hip fracture were 74.6% at one year and only 29.6% at seven years. Our findings supported the notion that being on HD is a risk for hip fracture. Additionally, old age, female gender, a prior hip fracture, osteoporosis, DM and liver cirrhosis were also risk factors for hip fracture in patients with ESRD and undergoing dialysis.
慢性肾脏病会增加髋部骨折的风险。髋部骨折与死亡率增加、生活质量下降以及更高的经济负担相关。为了确定透析方式是否与终末期肾病(ESRD)患者髋部骨折的更高发病率相关,我们使用台湾国民健康保险研究数据库来检查1999年至2005年间开始透析的51473例患者的记录。对这些患者进行随访直至死亡、移植、停止透析或2008年12月31日。随访期为(均值±标准差)4.14±2.48年。使用Kaplan-Meier方法计算髋部骨折的累积发病率。使用Cox模型确定髋部骨折的预测因素。在研究期间,1903例患者发生了髋部骨折。髋部骨折的总体发病率为89.21/10000患者年。接受血液透析(HD)的患者髋部骨折的发病率比接受腹膜透析(PD)的患者高31%(风险比1.31,95%置信区间:1.01-1.70)。65岁及以上的患者发生髋部骨折的风险是18-44岁患者的13倍多(风险比:13.65;95%置信区间:10.12-18.40)。增加髋部骨折风险的其他因素包括既往髋部骨折(风险比:1.44;95%置信区间:1.15-1.80)、骨质疏松症(风险比:1.24;95%置信区间:1.07-1.45)、糖尿病(风险比:1.66;95%置信区间:1.51-1.83)和肝硬化(风险比:1.37,95%置信区间:1.15-1.64)。总体住院死亡率为3.2%。髋部骨折后的累积生存率在1年时为74.6%,在7年时仅为29.6%。我们的研究结果支持接受HD是髋部骨折的一个风险因素这一观点。此外,老年、女性、既往髋部骨折、骨质疏松症、糖尿病和肝硬化也是ESRD透析患者髋部骨折的风险因素。